Answer
Crovalimab (PiaSky) may be considered during pregnancy if the woman's clinical condition requires treatment, although there are no data in pregnant women and crovalimab may potentially cause terminal complement inhibition in the foetal circulation.
Sources for this answer
- PiaSky 340 mg solution for injection/infusionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked